{"DataElement":{"publicId":"6346012","version":"1","preferredName":"Exemestane Prevention Study Eligibility Determination Category","preferredDefinition":"The criteria to determine eligibility of patients for the exemestane trial.","longName":"EXEME_STDY_ELIG_CAT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"6345997","version":"1","preferredName":"Exemestane Prevention Study Eligibility Determination","preferredDefinition":"A synthetic androgen analogue.  Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. (NCI04)_A type of study protocol designed to evaluate intervention(s) for disease prevention._Criteria to determine eligibility of patients for medical care programs and services.","longName":"2867186v1.0:6345995v1.0","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2867186","version":"1","preferredName":"Exemestane","preferredDefinition":"A synthetic androgen analogue.  Exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. (NCI04)","longName":"C1097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exemestane","conceptCode":"C1097","definition":"An irreversible steroidal aromatase inhibitor, with antiestrogen and antineoplastic activities. Upon oral administration, exemestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the peripheral aromatization of androgens, including androstenedione and testosterone, to estrogens. This lowers estrogen levels in the blood circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"691BE905-FF2C-757A-E040-BB89AD4317AE","latestVersionIndicator":"Yes","beginDate":"2009-05-04","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-05-04","modifiedBy":"ONEDATA","dateModified":"2009-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6345995","version":"1","preferredName":"Prevention Study Eligibility Determination","preferredDefinition":"A type of study protocol designed to evaluate intervention(s) for disease prevention.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C49657:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prevention Study","conceptCode":"C49657","definition":"A type of study protocol designed to evaluate intervention(s) for disease prevention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7046343D-8488-372B-E053-F662850AA3FC","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7046343D-8499-372B-E053-F662850AA3FC","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"MAESKEB","dateModified":"2018-07-11","changeDescription":"Curated for MDA2014-04-01 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6346008","version":"1","preferredName":"Eligibility Determination Category","preferredDefinition":"Criteria to determine eligibility of patients for medical care programs and services._A grouping of items based on some commonality or by user defined characteristics.","longName":"6346008v1.0","context":"DCP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL I HAVE UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO ALLOW RESEARCHERS TO HAVE ACCESS TO MY BIOPSY TO TEST FOR THE ESTROGEN RECEPTOR","valueDescription":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL I HAVE UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO ALLOW RESEARCHERS TO HAVE ACCESS TO MY BIOPSY TO TEST FOR THE ESTROGEN RECEPTOR","ValueMeaning":{"publicId":"6346009","version":"1","preferredName":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL I HAVE UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO ALLOW RESEARCHERS TO HAVE ACCESS TO MY BIOPSY TO TEST FOR THE ESTROGEN RECEPTOR","longName":"6346009","preferredDefinition":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL\r\nI HAVE UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO ALLOW RESEARCHERS TO HAVE ACCESS TO MY BIOPSY TO TEST FOR THE ESTROGEN RECEPTOR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70464596-5330-4F72-E053-F662850A5DC7","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"70464596-5349-4F72-E053-F662850A5DC7","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","deletedIndicator":"No"},{"value":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL. I HAVE NOT UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO UNDERGO A BIOPSY FOR RESEARCH AND TESTING FOR THE ESTROGEN RECEPTOR","valueDescription":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL. I HAVE NOT UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO UNDERGO A BIOPSY FOR RESEARCH AND TESTING FOR THE ESTROGEN RECEPTOR","ValueMeaning":{"publicId":"6346010","version":"1","preferredName":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL. I HAVE NOT UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO UNDERGO A BIOPSY FOR RESEARCH AND TESTING FOR THE ESTROGEN RECEPTOR","longName":"6346010","preferredDefinition":"I WISH TO DETERMINE WHETHER I AM ELIGIBLE FOR THE EXEMESTANE TRIAL.\r\nI HAVE NOT UNDERGONE A BREAST TISSUE BIOPSY FOR DIAGNOSIS OF MY CURRENT BREAST NODULE AND I AGREE TO UNDERGO A BIOPSY FOR RESEARCH AND TESTING FOR THE ESTROGEN RECEPTOR","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70464596-5353-4F72-E053-F662850A5DC7","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"70464596-536C-4F72-E053-F662850A5DC7","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6346007","version":"1","preferredName":"Eligibility Determination Category","preferredDefinition":"Criteria to determine eligibility of patients for medical care programs and services.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C25171:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70464596-5308-4F72-E053-F662850A5DC7","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"ONEDATA","dateModified":"2018-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70464596-5319-4F72-E053-F662850A5DC7","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"MAESKEB","dateModified":"2018-07-11","changeDescription":"Curated for MDA2014-04-01 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Participant Eligibility Check","type":"Preferred Question Text","description":"Participant Eligibility Checkbox","url":null,"context":"DCP"}],"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"70465810-106F-5DA1-E053-F662850AC28C","latestVersionIndicator":"Yes","beginDate":"2018-07-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2018-07-05","modifiedBy":"MAESKEB","dateModified":"2018-07-11","changeDescription":"Curated for MDA2014-04-01 bsm.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}